Table 4.
Baseline characteristics of patients
| Feedback plus worksheet | Feedback alone | ICC | |
|---|---|---|---|
|
Patients (total = 4,617) |
2,157 |
2,460 |
- |
| IHD only |
545 (25%) |
637 (26%) |
- |
| DM only |
1,329 (62%) |
1,534 (62%) |
- |
| IHD and DM |
283 (13%) |
289 (12%) |
- |
| Age (mean years ± sd) |
67 ±14 |
65 ±14 |
- |
| Female |
906 (42%) |
1,251 (46%) |
- |
| WT (mean kg ± sd) |
88 ±22 |
90 ±29 |
0.047 |
| Systolic BP (mean mmHg ± sd) |
130 ±18 |
129 ±17 |
0.058 |
| Diastolic BP (mean mmHg ± sd) |
73 ±11 |
75 ±11 |
0.079 |
| LDL (mean mmol/l ± sd) |
2.3 ±0.9 |
2.3 ±0.9 |
0.053 |
| HbA1c^ (mean% ± sd) |
7.4 ±1.4 |
7.3 ±1.4 |
0.011 |
| LDL at target~ |
665 (31%) |
826 (34%) |
0.051 |
| BP at target~ |
1,019 (47%) |
1,054 (43%) |
0.071 |
| BP test in 6 M |
1,839 (85%) |
1,831 (74%) |
0.183 |
| A1C test in 6 M^ |
1,267 (79%) |
1,250 (69%) |
0.079 |
| FBG test in 24 M |
1,904 (88%) |
2,134 (87%) |
0.091 |
| LDL test in 12 M |
1,574 (73%) |
1,770 (72%) |
0.096 |
| ACR test in 12 M^ |
1,044 (65%) |
1,232 (68%) |
0.195 |
| Rx ASA* |
602 (73%) |
657 (71%) |
0.092 |
| Rx Statin |
1,463 (68%) |
1,757 (71%) |
0.051 |
| Rx ACE/ARB^ |
1,153 (71%) |
1,243 (68%) |
0.068 |
| Rx Beta blocker* |
497 (60%) |
562 (61%) |
0.008 |
| Rx insulin^ |
339 (21%) |
391 (21%) |
0.006 |
| Composite process score (mean ± sd) | 73 ±25 | 71 ±27 | 0.106 |
Legend: ICC = Intra-cluster correlation reported at physician-level, ^ = Calculated for patients with diabetes, * Calculated for patients with IHD, ~ = Target BP 130/80 for diabetes but 140/90 for IHD and Target LDL < 2, IHD = ischemic heart disease, BP = blood pressure, A1C = haemoglobin A1c, FBG = fasting blood glucose, LDL = low density lipoprotein cholesterol, ACR = urinary albumin-to-creatinine ratio, ASA = aspirin, ACE/ARB = angiotensin-modifying agent, kg = kilogram, sd = standard deviation.